ASND Ascendis Pharma A/S
Nasdaq · SEC CIK 1612042 · EDGAR
- Bought, last 12 months
- $777.1K 5 purchases by 2 insiders
- Sold, last 12 months
- $5.51M 3 sales by 3 insiders
- Filings on record
- 8 since 2026-05-12, latest 2026-09-09 17:04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| JENSEN FLEMMING STEEN | See Remarks | — | $4.64M |
| Bodenhoff Mads | SVP, PAO | — | $810.6K |
| BIENAIME JEAN JACQUES | Dir | $699.3K | — |
| SMITH SCOTT THOMAS | EVP, CFO | $77.7K | — |
| HOLTUG LARS | Dir | — | $62.3K |
Transactions 9
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-09 17:04 | 2026-09-08 | ASND | Bodenhoff Mads | SVP, PAO | M - OptEx | $110.00 | +3,000 | 3,000 | New | +$330.0K |
| D | 2026-09-09 17:04 | 2026-09-08 | ASND | Bodenhoff Mads | SVP, PAO | S - Sale+OE | $270.19 | -3,000 | 0 | -100% | -$810.6K |
| 2026-09-03 16:09 | 2026-09-02 | ASND | HOLTUG LARS | Dir | S - Sale | $264.13 | -236 | 4,000 | -6% | -$62.3K | |
| M | 2026-08-18 21:02 | 2026-08-14 | ASND | BIENAIME JEAN JACQUES | Dir | P - Purchase | $246.33 | +2,000 | 2,900 | +222% | +$492.7K |
| 2026-06-02 16:25 | 2026-06-02 | ASND | SMITH SCOTT THOMAS | EVP, CFO | P - Purchase | $219.00 | +100 | 4,367 | +2% | +$21.9K | |
| M | 2026-06-01 16:11 | 2026-05-29 | ASND | BIENAIME JEAN JACQUES | Dir | P - Purchase | $223.12 | +500 | 900 | +125% | +$111.6K |
| 2026-06-01 16:10 | 2026-05-29 | ASND | SMITH SCOTT THOMAS | EVP, CFO | P - Purchase | $223.32 | +250 | 4,267 | +6% | +$55.8K | |
| M | 2026-05-27 16:05 | 2026-05-26 | ASND | BIENAIME JEAN JACQUES | Dir | P - Purchase | $237.80 | +400 | 400 | New | +$95.1K |
| 2026-05-12 16:08 | 2026-05-11 | ASND | JENSEN FLEMMING STEEN | See Remarks | S - Sale | $238.49 | -19.5K | 0 | -100% | -$4.64M |
Purchase Sale Sale after option exercise All abbreviations